The national budget proposal for the 2019 fiscal year includes a request for $13 billion in funding for opioid treatment and related services. This linked Newsweek article states that $3 billion would be allocated in 2018 and another $10 billion in 2019.
Many opioid treatment programs across the country are currently able to add patient slots when additional funding is made available. The opioid crisis has flooded many clinics that are already at maximum census due to limited State and Medicaid funding.
A number of private pay clinics have opened in recent years as the need for medication-assisted treatment increased. If a substantial allocation of government funds becomes available, opioid treatment services will finally come into sharp national focus as scores of people finally obtain the help they need to stabilize and to recover.
In treating opioid addiction, research has shown that traditional abstinence-based programs which do not utilize medication assistance have a failure rate of 90%. Medication-assistance is a critical factor in helping opioid addicted people move into sustained recovery. The proposed $13 billion earmarked for opioid treatment services can make a huge difference all across the U.S. Methadone or buprenorphine (suboxone) coupled with counseling and drug testing comprise the gold standard of care in treating opioid addiction.
Posted in Addiction Recovery, Buprenorphine, Drug Treatment, Methadone, Methadone Benefits, Methadone Clinics, Methadone Maintenance, Methadone News, Opiate Treatment, Suboxone, Suboxone Doctors
Right Path provide a variety of opioid, alcohol, and other drug addiction treatment services through their various outpatient programs located in Virginia and North Carolina.
The organization utilizes Medication-Assisted Treatment (MAT) for opioid use disorders, and they provide confidential consultation to individuals who are trying to determine the best of course of treatment for dealing with their addiction issues. Right Path are equipped to now provide the new Probuphine implant that utilizes time-released buprenorphine to alleviate opioid withdrawal symptoms as individuals pursue a solid, long-term personal recovery.
Right Path endorse the benefits of 12 Step philosophy while also incorporating a strong medical component in their opioid recovery program due to the statistically high percentage of opioid addicted people who will ultimately relapse without medication-assisted support.
Read more about Right Path’s services and counseling approach at the link above.
Posted in Addiction Counseling, Addiction Recovery, Buprenorphine, Methadone, Opiate Treatment, Recovery, Suboxone, Suboxone Clinics, Suboxone Doctors, Suboxone Physicians
Tagged outpatient treatment, Right Path
Many state-funded addiction treatment services have undergone gradual cuts during the last 15 years. With the rising opioid addiction crisis in America, better access to opioid treatment is definitely needed.
There are a number of private clinics and outpatient treatment centers opening their doors in most every state. These private clinics are meeting a need for services that are often absent in more remote areas of the country.
Some new opioid treatment providers are smaller, independent methadone clinics while others are part of a larger network such as those owned by Acadia Healthcare, Behavioral Health Group (BHG), or Colonial Management Group.
They all have one thing in common, and it is that they provide their patients with medication-assisted treatment (MAT). MAT is scientifically proven to be more effective than other forms of abstinence-based treatment.
Medication assistance typically utilizes methadone or buprenorphine-based products to alleviate a patient’s chronic opioid withdrawal. Without medication-assistance, patients often face either a detox admission or they struggle on in a daily effort to secure opiates so as to prevent the return of withdrawal sickness.
People ready for opioid treatment may find that their local methadone clinic is full, or that their nearest clinic is just too far away to access on a daily basis. For some patients, suboxone/buprenorphine may be the best solution since a prescription can be obtained for several weeks of medication before a return visit is required.
Access to treatment is currently on the radar of national healthcare officials and government legislators, many of whom have received numerous letters and calls from families requesting more funding for treatment, and better access. Media coverage has also been much improved during the past 3 years in part due to the widespread opioid crisis and its broad impact.
Supporting local opioid addiction treatment services is important for every community. It ultimately saves lives, reduces crime, and promotes recovery so that addicted patients can work and function.
It was announced in June that North Dakota would be receiving its first methadone clinic. North Dakota and Wyoming are the only two states in the U.S. that have yet to provide a methadone treatment program for opioid addiction.
The region has suffered in recent years with an increase in the use of heroin and fentanyl, and with associated opioid overdoses. Kurt Snyder is the Executive Director of the new clinic, Heartview Foundation. Mr. Snyder echoed the research-based evidence showing that medication-assisted treatment for opioid addiction provides superior results to abstinence-only treatment interventions.
In the article linked above from The Jamestown Sun, a local police detective indicated that the addiction problem had recently worsened in North Dakota as a result of the price of drugs dropping.
The Heartview Foundation clinic will also offer buprenorphine and naloxone in addition to methadone thus providing a more complete range of medication assisted therapies. Therapeutic counseling and mental health treatment will be a component of the Heartview program as well as drug testing.
Of particular benefit too is the recent initiative in North Dakota that will allow pharmacists the ability to prescribe naloxone so that opioid overdoses can hopefully be greatly reduced. The ready accessibility of naloxone is receiving a nationwide push as communities struggle to address overdose concerns.
Methadone.US welcomes a new addition to the featured clinics here on the site with the listing of BrookStone Medical Center in St. George, Utah.
Posted in Addiction Treatment, Buprenorphine, Drug Rehab Programs, Drug Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Suboxone, Suboxone Doctors
Tagged Kurt Snyder, medication assisted treatment, methadone clinic north dakota, north dakota
The growing problem around opioid addiction continues to receive coverage in the media, and it has become a topic of discussion on the campaign trail because candidates are being approached throughout the country by concerned families and citizens.
Marcia Taylor, President of Partnership For Drug Free Kids, provided testimony in January to a Senate Judiciary Committee on the need to increase funding for drug prevention and drug treatment. Proposed for consideration is the CARA Senate Bill which stands for Comprehensive Addiction and Recovery Act. CARA would allocate funding for drug treatment and prevention resources with a goal of getting more addicted individuals into treatment, and better educating both parents and teens on the dangers of recreational opioid use.
CARA would also address the need to distribute naloxone across the U.S. to aid in the fight to reduce deaths from opioid overdose. Local law enforcement would be trained on the administration of naloxone. Prescription drug monitoring programs would also receive increased support under CARA.
Methadone and Suboxone have become familiar interventions for anyone knowledgeable on opioid addiction issues. Most state-funded opioid treatment programs in the United States are currently full and have waiting lists of addicted people who are eager to participate in medication-assisted treatment.
In America, there has been a notable expansion in recent years of treatment programs who utilize methadone or suboxone to help patients. While many of these programs are private self-pay, Medicaid presently pays for methadone-based treatment approaches in a number of U.S. states. The number of private pay programs currently outnumber state-funded and Medicaid-funded programs by a substantial margin.